long intergenic non-protein coding RNA 1173Genealiases: []
Q-omics provides the consensus-scored LINC01173 profile across patient tissues and cancer cell-line models. LINC01173 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, LINC01173 is differentially expressed in 8, with the highest sampling consensus in HNSC. Additionally, LINC01173 RNA expression shows 6,879 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight HNSC, and TGCT as cancer lineages where LINC01173 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01173 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01173 survival associations across molecular data types. LINC01173 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01173 RNA expression–survival associations across cancer types. High LINC01173 expression shows unfavorable associations in HNSC, READ, KIRC, LGG and LAML, but favorable associations in STAD. The HNSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify HNSC as the clearest survival context for LINC01173 RNA expression.
This table summarizes LINC01173 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01173. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01173 shows lower tumor expression in KICH and higher tumor expression in HNSC, KIRP, UCEC, LUSC and PRAD. The HNSC box plot shows higher LINC01173 RNA expression in tumor versus normal tissue (log2 FC = +0.127, t-test p = .001).
This table shows molecular features associated with LINC01173 in patient tissues and cancer cell lines. In patient samples, LINC01173 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
